Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
A one-shot gene-editing cholesterol therapy could soon be a reality
A one-shot gene-editing cholesterol therapy could soon be a reality
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Subscribe To Our Newsletter & Stay Updated